ES2039386T3 - Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos. - Google Patents

Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.

Info

Publication number
ES2039386T3
ES2039386T3 ES198787112384T ES87112384T ES2039386T3 ES 2039386 T3 ES2039386 T3 ES 2039386T3 ES 198787112384 T ES198787112384 T ES 198787112384T ES 87112384 T ES87112384 T ES 87112384T ES 2039386 T3 ES2039386 T3 ES 2039386T3
Authority
ES
Spain
Prior art keywords
oxolabdanes
preparing
procedure
prepare medicines
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787112384T
Other languages
English (en)
Inventor
Nicholas Joseph Hrib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2039386T3 publication Critical patent/ES2039386T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A OXOLABDANOS Y A UN PROCEDIMIENTO PARA SU PREPARACION. LOS COMPUESTOS DE LA INVENCION SON CAPACES DE REDUCIR LA PRESION INTRAOCULAR Y PUEDEN EMPLEARSE CON ESTE OBJETO, EN MEDICAMENTOS.
ES198787112384T 1986-08-28 1987-08-26 Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos. Expired - Lifetime ES2039386T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/901,337 US4740522A (en) 1986-08-28 1986-08-28 Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure

Publications (1)

Publication Number Publication Date
ES2039386T3 true ES2039386T3 (es) 1993-10-01

Family

ID=25413969

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787112384T Expired - Lifetime ES2039386T3 (es) 1986-08-28 1987-08-26 Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.

Country Status (9)

Country Link
US (3) US4740522A (es)
EP (1) EP0257631B1 (es)
JP (1) JPS6388175A (es)
AT (1) ATE69223T1 (es)
DE (1) DE3774367D1 (es)
DK (1) DK447587A (es)
ES (1) ES2039386T3 (es)
GR (1) GR3003638T3 (es)
PT (1) PT85602B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130332A (en) * 1986-08-28 1992-07-14 Hoechst Roussel Pharmaceuticals Inc. Oxolabdanes
US4978678A (en) * 1986-11-20 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 12-halogenated forskolin derivatives
US5177207A (en) * 1989-01-11 1993-01-05 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US4999351A (en) * 1989-01-11 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (de) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
US4564626A (en) * 1983-04-01 1986-01-14 Schering Corporation Methods of inducing bronchodilation
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
AU2690684A (en) * 1984-02-24 1985-09-10 Kenji Adachi Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
DE3407514A1 (de) * 1984-03-01 1985-09-26 Hoechst Ag, 6230 Frankfurt Verwendung von polyoxygenierten labdanderivaten zur behandlung von konstriktionen der atemwege
ATE60767T1 (de) * 1984-12-14 1991-02-15 Hoechst Roussel Pharma Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
US4639446A (en) * 1984-12-14 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Aminoacyllabdanes, pharmaceutical compositions and use
DE3502685A1 (de) * 1985-01-26 1986-09-04 Hoechst Ag, 6230 Frankfurt Forskolin, seine analoge und derivate, verfahren zu deren herstellung mittels mikrobieller umwandlungen und die anwendung dieser verbindungen als arzneimittel
DE3678736D1 (de) * 1985-03-01 1991-05-23 Hoechst Roussel Pharma Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
US4851397A (en) * 1985-03-01 1989-07-25 Hoechst-Roussel Pharmaceuticals Inc. Labdanes, pharmaceutical compositions, and their use
US4677103A (en) * 1985-03-01 1987-06-30 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
DE3527336A1 (de) * 1985-07-31 1987-02-05 Hoechst Ag Verfahren zur mikrobiellen hydroxylierung von forskolin und seinen derivaten durch neurospora crassa
IN166900B (es) * 1987-06-03 1990-08-04 Hoechst India
DE3730748A1 (de) * 1987-06-06 1988-12-22 Hoechst Ag Neue polyoxygenierte labdanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
US4883885A (en) 1989-11-28
GR3003638T3 (es) 1993-03-16
PT85602A (en) 1987-09-01
EP0257631A3 (en) 1988-08-17
PT85602B (pt) 1990-05-31
ATE69223T1 (de) 1991-11-15
DK447587A (da) 1988-02-29
EP0257631B1 (en) 1991-11-06
DK447587D0 (da) 1987-08-27
EP0257631A2 (en) 1988-03-02
US4740522A (en) 1988-04-26
JPS6388175A (ja) 1988-04-19
US4933476A (en) 1990-06-12
DE3774367D1 (de) 1991-12-12

Similar Documents

Publication Publication Date Title
ES557152A0 (es) Un procedimiento para preparar laudanos
FI871294A (fi) Menetelmä lääkeaineina käyttökelpoisten milbemysiinin johdannaisten valmistamiseksi
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
ATE55985T1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
EP0268256A3 (en) 12-halogenated forskolin derivatives, intermediates and a process for the preparation thereof and their use as medicaments
PT85454A (de) Verwendung von 15-deoxyspergualin als arzneimittel
DE3061907D1 (en) 6-imidazol-1-yl-3-hydrazino-pyridazines, process for preparing them and medicaments containing them
DK311284D0 (da) 3-(4'-aminobutylamino)-propylamino-bleomycin-derivater, deres fremstilling og deres anvendelse som laegemidler
ZA793991B (en) Novel prostaglandin derivatives of the delta 2-11-desoxy-pgf2 or pge2 series,process for their manufacture and their use as medicaments
MX8938A (es) Nuevos derivados del acido 1,5-difenilpirazol-3-carboxilico y procedimiento para su preparacion
MX2205A (es) Procedimiento para la preparacion de derivados de aminofenol y compuestos obtenidos a partir del mismo.
UA7019A1 (uk) Спосіб отримання похідних сульфонілдіаміда
FI97808C (fi) Menetelmä lääkeaineina käyttökelpoisten milbemysiinin johdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 257631

Country of ref document: ES